We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+4.74%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$61.7B
AUM Growth
+$546M
(+0.89%)
Cap. Flow
-$4.01B
Cap. Flow
% of AUM
-6.5%
Top 10 Holdings %
Top 10 Hldgs %
23.47%
Holding
1,295
New
145
Increased
379
Reduced
411
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$218M |
| 2 |
Bank of America
BAC
|
+$205M |
| 3 |
Dollar General
DG
|
+$198M |
| 4 |
Union Pacific
UNP
|
+$197M |
| 5 |
Elevance Health
ELV
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$505M |
| 2 |
Rockwell Automation
ROK
|
+$373M |
| 3 |
CHL
China Mobile Limited
CHL
|
+$294M |
| 4 |
eBay
EBAY
|
+$222M |
| 5 |
TSMC
TSM
|
+$220M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.38% |
| 2 | Healthcare | 15.97% |
| 3 | Financials | 13.78% |
| 4 | Industrials | 11.75% |
| 5 | Communication Services | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
ICU Medical
ICUI
$4.16B
| $20.1M | 0.03% |
79,600
-1,800
| -2% | -$417K |
|
302
Keysight
KEYS
$50.7B
| $19.8M | 0.03% |
220,253
+59,782
| +37% | +$5.07M |
|
303
PENN Entertainment
PENN
$2.84B
| $19.6M | 0.03% |
1,019,215
+207,563
| +26% | +$4.21M |
|
304
Gilead Sciences
GILD
$165B
| $18.9M | 0.03% |
280,030
+66,542
| +31% | +$4.38M |
|
305
Zebra Technologies
ZBRA
$13.5B
| $18.8M | 0.03% |
89,719
+35,378
| +65% | +$7.13M |
|
306
CAE Inc. Common Shares
CAE
$8.44B
| $18.7M | 0.03% |
694,992
+88,301
| +15% | +$2.16M |
|
|
DFS
307
DELISTED
Discover Financial Services
DFS
| $18.6M | 0.03% |
239,124
+8,741
| +4% | +$677K |
|
308
Vanguard FTSE Europe ETF
VGK
$30.1B
| $18.4M | 0.03% |
335,058
-59,043
| -15% | -$3.22M |
|
|
VAR
309
DELISTED
Varian Medical Systems, Inc.
VAR
| $18.3M | 0.03% |
134,558
+12,440
| +10% | +$1.66M |
|
|
AEF
310
abrdn Emerging Markets Equity Income Fund
AEF
$329M
| $17.6M | 0.03% |
2,402,300
+200,677
| +9% | +$1.46M |
|
311
Grupo Aeroportuario del Pacifico
PAC
$12.9B
| $17.3M | 0.03% |
165,907
+4,382
| +3% | +$444K |
|
312
Alexandria Real Estate Equities
ARE
$9.37B
| $16.5M | 0.03% |
117,188
-32,579
| -22% | -$4.7M |
|
|
ETFC
313
DELISTED
E*Trade Financial Corporation
ETFC
| $16.5M | 0.03% |
369,195
+347,539
| +1,605% | +$16.6M |
|
314
Ulta Beauty
ULTA
$21.8B
| $16.4M | 0.03% |
47,369
+6,129
| +15% | +$2.12M |
|
315
Public Service Enterprise Group
PEG
$38.7B
| $16.4M | 0.03% |
279,128
+86,870
| +45% | +$5.18M |
|
316
Lam Research
LRCX
$316B
| $16.3M | 0.03% |
867,060
+312,920
| +56% | +$5.94M |
|
317
Sabesp
SBS
$18.4B
| $16.3M | 0.03% |
6,896,756
-67,447
| -1% | -$147K |
|
318
Pegasystems
PEGA
$5.09B
| $16.3M | 0.03% |
456,768
-11,250
| -2% | -$401K |
|
|
AL
319
DELISTED
Air Lease Corp
AL
| $16.1M | 0.03% |
388,518
+34,344
| +10% | +$1.31M |
|
320
Altria Group
MO
$125B
| $16.1M | 0.03% |
339,070
+177,531
| +110% | +$9.3M |
|
321
Cardinal Health
CAH
$53.7B
| $16M | 0.03% |
338,949
-45,530
| -12% | -$2.1M |
|
322
Aflac
AFL
$65.5B
| $15.9M | 0.03% |
290,528
-70,339
| -19% | -$3.63M |
|
|
EV
323
DELISTED
Eaton Vance Corp.
EV
| $15.8M | 0.03% |
367,329
+1,397
| +0.4% | +$57K |
|
324
Lincoln National
LNC
$7.92B
| $15.8M | 0.03% |
245,691
+187,239
| +320% | +$12M |
|
325
Allstate
ALL
$70.6B
| $15.7M | 0.03% |
154,302
+42,388
| +38% | +$4.14M |
|
Similar funds
QCM
Lazard Asset Management's Q2 2019 Portfolio in Review
As of Q2 2019, Lazard Asset Management held 1,295 positions worth $61.7B, up 0.89% from $61.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $4.01B in Q2 2019, closing 104 positions and reducing 411 holdings. Its most notable exit was Utah Medical Products, an estimated $13.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Sabre worth $132M.
- Lazard Asset Management's largest Q2 2019 buy was Sabre: 5,927,264 shares worth $132M.
- Lazard Asset Management added most to Walt Disney in Q2 2019, an estimated $218M increase.
- Lazard Asset Management's biggest Q2 2019 reduction was Wells Fargo, cutting an estimated $505M.
- Lazard Asset Management fully exited Utah Medical Products in Q2 2019, selling an estimated $13.7M.
- Lazard Asset Management's ten largest holdings make up 23% of its $61.7B portfolio in Q2 2019.
- Lazard Asset Management opened 145 new positions and closed 104 in Q2 2019.
- Lazard Asset Management's portfolio value rose 0.89% quarter-over-quarter to $61.7B.
Based on Lazard Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.